Cargando…

Circulating tumor cells in newly diagnosed inflammatory breast cancer

INTRODUCTION: Circulating tumor cells (CTCs) are an independent prognostic factor for progression-free survival (PFS) and overall survival (OS) in patients with metastatic breast cancer. Inflammatory breast cancer (IBC) is one of the most aggressive forms of breast cancer. The prognostic value of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mego, Michal, Giordano, Antonio, De Giorgi, Ugo, Masuda, Hiroko, Hsu, Limin, Giuliano, Mario, Fouad, Tamer M, Dawood, Shaheenah, Ueno, Naoto T, Valero, Vicente, Andreopoulou, Eleni, Alvarez, Ricardo H, Woodward, Wendy A, Hortobagyi, Gabriel N, Cristofanilli, Massimo, Reuben, James M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318180/ https://www.ncbi.nlm.nih.gov/pubmed/25572591 http://dx.doi.org/10.1186/s13058-014-0507-6

Ejemplares similares

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2016)

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
por: Mego, M, et al.
Publicado: (2016)

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
por: Mego, M, et al.
Publicado: (2009)

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
por: Giuliano, Mario, et al.
Publicado: (2011)

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
por: Giuliano, Mario, et al.
Publicado: (2014)

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
por: Mego, Michal, et al.
Publicado: (2012)

Update on systemic treatment for newly diagnosed inflammatory breast cancer
por: Chainitikun, Sudpreeda, et al.
Publicado: (2020)

Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer
por: Kogawa, Takahiro, et al.
Publicado: (2015)

High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2(+) Inflammatory Breast Cancer
por: Anfossi, Simone, et al.
Publicado: (2014)

American Society of Clinical Oncology 2014: Updates in breast and gastrointestinal cancers
por: Dawood, Shaheenah
Publicado: (2014)

Breast and gastrointestinal cancer updates from ASCO 2015
por: Dawood, Shaheenah
Publicado: (2015)

Updates from the 2014 San antonio breast cancer symposium
por: Dawood, Shaheenah
Publicado: (2015)

Updates from Gastrointestinal ASCO 2015
por: Dawood, Shaheenah
Publicado: (2015)

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells
por: Cohen, Evan N., et al.
Publicado: (2015)

Novel therapeutic strategies in the treatment of triple-negative breast cancer
por: Oualla, Karima, et al.
Publicado: (2017)

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
por: Fouad, Tamer M., et al.
Publicado: (2018)

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
por: Masuda, Hiroko, et al.
Publicado: (2017)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
por: Wang, Xiaoping, et al.
Publicado: (2017)

Entrectinib for NTRK Fusion-Positive Metastatic Melanoma Progressing on Combined PD-1 and CTLA-4 Inhibition: A Case Report
por: Dawood, Shaheenah, et al.
Publicado: (2023)

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
por: Kida, Kumiko, et al.
Publicado: (2020)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer
por: Ning, Jing, et al.
Publicado: (2019)

Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors
por: Chovanec, Michal, et al.
Publicado: (2018)

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival
por: Stecklein, Shane R., et al.
Publicado: (2017)

Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome
por: Rejlekova, Katarina, et al.
Publicado: (2019)

Statin use in primary inflammatory breast cancer: a cohort study
por: Brewer, T M, et al.
Publicado: (2013)

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
por: Debeb, Bisrat G, et al.
Publicado: (2014)

Negative Effects On Cancer Care Due To COVID-19 Implications: Observations From A Cancer Center In The UAE
por: Dawood, Shaheenah, et al.
Publicado: (2020)

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016)

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
por: Krishnamurthy, Savitri, et al.
Publicado: (2013)

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells
por: Debeb, Bisrat G, et al.
Publicado: (2010)

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
por: Sirohi, Bhawna, et al.
Publicado: (2016)

ASCO Leadership Development Program: International Perspectives
por: De Guzman, Roselle, et al.
Publicado: (2018)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference
por: Ueno, Naoto T., et al.
Publicado: (2018)

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
por: Rypens, Charlotte, et al.
Publicado: (2022)

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt
por: Bartholomeusz, Chandra, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g8118548fjem3q257vr9kqh1ro